Christopher S. Boerner - Net Worth and Insider Trading
Christopher S. Boerner Net Worth
The estimated net worth of Christopher S. Boerner is at least $22 Million dollars as of 2025-07-25. Christopher S. Boerner is the Executive Vice President, Comm of Seagen Inc and owns about 72,358 shares of Seagen Inc (SGEN) stock worth over $17 Million. Christopher S. Boerner is also the CEO of Bristol-Myers Squibb Co and owns about 104,626 shares of Bristol-Myers Squibb Co (BMY) stock worth over $5 Million. Details can be seen in Christopher S. Boerner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher S. Boerner has not made any transactions after 2025-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher S. Boerner
Christopher S. Boerner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher S. Boerner owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , Seagen Inc (SGEN) , and Achaogen Inc (AKAOQ) .
Click here to see the complete history of Christopher S. Boerner’s form 4 insider trades.
Insider Ownership Summary of Christopher S. Boerner
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2025-02-20 | EVP & Chief Commercial Officer |
| SGEN | Seagen Inc | 2014-08-24 | SVP & Commercial |
| AKAOQ | Achaogen Inc | 2014-03-27 | director |
Christopher S. Boerner Latest Holdings Summary
Christopher S. Boerner currently owns a total of 2 stocks. Among these stocks, Christopher S. Boerner owns 72,358 shares of Seagen Inc (SGEN) as of August 24, 2014, with a value of $17 Million and a weighting of 76.37%. Christopher S. Boerner also owns 104,626 shares of Bristol-Myers Squibb Co (BMY) as of February 20, 2025, with a value of $5 Million and a weighting of 23.63%.
Latest Holdings of Christopher S. Boerner
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2014-08-24 | 72,358 | 228.74 | 16,551,169 |
| BMY | Bristol-Myers Squibb Co | 2025-02-20 | 104,626 | 48.94 | 5,120,396 |
Holding Weightings of Christopher S. Boerner
Christopher S. Boerner Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher S. Boerner has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 1,248 shares on August 24, 2014, which brought Christopher S. Boerner around $54,350.
According to the SEC Form 4 filings, Christopher S. Boerner has made a total of 3 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 2,000 shares on February 20, 2025, which cost Christopher S. Boerner around $110,100.
Insider Trading History of Christopher S. Boerner
- 1
Christopher S. Boerner Trading Performance
GuruFocus tracks the stock performance after each of Christopher S. Boerner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher S. Boerner is -2.31%. GuruFocus also compares Christopher S. Boerner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher S. Boerner within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher S. Boerner's insider trading performs compared to the benchmark.
Performance of Christopher S. Boerner
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.66 | | | | | |
| Relative Return to S&P 500(%) | 5.51 | | | | | |
Christopher S. Boerner Ownership Network
Ownership Network List of Christopher S. Boerner
Ownership Network Relation of Christopher S. Boerner
Christopher S. Boerner Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Christopher S. Boerner is the EVP & Chief Commercial Officer of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Christopher S. Boerner made 1 insider transaction in Bristol-Myers Squibb Co (BMY) with a net purchase of 2,000. Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 7,903 shares made by Samit Hirawat , a net sale of 700 shares made by , and a net sale of 97 shares made by Benjamin Hickey .
In summary, during the past 3 months, insiders sold 97 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 97 shares. During the past 18 months, 797 shares of Bristol-Myers Squibb Co (BMY) were sold and 9,903 shares were bought by its insiders, resulting in a net purchase of 9,106 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Christopher S. Boerner Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher S. Boerner. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher S. Boerner's mailing address is: Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
